14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
DRGN vs BOTT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Themes China Generative Artificial Intelligence ETF (DRGN) is the stronger overall head-to-head candidate over Themes ETF Trust Themes Humanoid Robotics ETF (BOTT) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). DRGN carries a Unified Composite Score of 41.6/100 (SELL) at $23.94 (N/M Forward P/E, N/A operating margin), whereas BOTT carries 40.5/100 (SELL) at $29.84 (N/M Forward P/E, N/A operating margin).
Defensive Composite Rating Caution: Although DRGN compares more favorably head-to-head, both DRGN (41.6/100 SELL) and BOTT (40.5/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: DRGN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.8); meanwhile BOTT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DRGN vs BOTT. Trailing 12-month operating profitability (DRGN N/A vs BOTT N/A) and valuation multiples (DRGN N/M vs BOTT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ DRGN vs BOTT Key Questions & Quantitative Answers
As of Nov 20, 2026, Themes China Generative Artificial Intelligence ETF (DRGN) is the stronger overall head-to-head candidate over Themes ETF Trust Themes Humanoid Robotics ETF (BOTT) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). DRGN carries a Unified Composite Score of 41.6/100 (SELL) at $23.94 (N/M Forward P/E, N/A operating margin), whereas BOTT carries 40.5/100 (SELL) at $29.84 (N/M Forward P/E, N/A operating margin). Defensive Composite Rating Caution: Although DRGN compares more favorably head-to-head, both DRGN (41.6/100 SELL) and BOTT (40.5/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: DRGN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.8); meanwhile BOTT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
DRGN and BOTT split Growth & Scale metrics: DRGN posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with BOTT at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, DRGN generates N/A in USD-normalized revenue versus N/A for BOTT. In operating R&D and SG&A reinvestment, DRGN deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BOTT.
DRGN and BOTT trade at balanced relative valuation multiples. DRGN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BOTT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DRGN (N/A ROE) versus BOTT (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, DRGN carries 53.1% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.35β · 42% Vol realized risk). By comparison, BOTT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.05β · 52% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.